Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review

BACKGROUND: EDTA is an intravenous chelating agent with high affinity to divalent cations (lead, cadmium, and calcium) that may be beneficial in the treatment of cardiovascular disease (CVD). Although a large randomized clinical trial showed benefit, smaller studies were inconsistent. We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravalli, Filippo, Vela Parada, Xavier, Ujueta, Francisco, Pinotti, Rachel, Anstrom, Kevin J., Lamas, Gervasio A., Navas‐Acien, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075296/
https://www.ncbi.nlm.nih.gov/pubmed/35229619
http://dx.doi.org/10.1161/JAHA.121.024648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075296/
https://www.ncbi.nlm.nih.gov/pubmed/35229619
http://dx.doi.org/10.1161/JAHA.121.024648

Ejemplares similares